Middle East Healthcare Co. (Saudi German Hospital) reported a net profit of SAR 141.56 million in the first nine months of 2018, a 40.2 percent year-on-year (YoY) drop attributed to higher cost of sales, increased depreciation expenses and higher salaries’ cost on the newly-opened Beverly clinics.
Item | 9m 2017 | 9m 2018 | Change |
---|---|---|---|
Revenues | 1,097.79 | 1,080.01 | (1.6 %) |
Gross Income | 452.40 | 389.19 | (14.0 %) |
Operating Income | 221.71 | 138.77 | (37.4 %) |
Net Income | 236.80 | 141.56 | (40.2 %) |
Average Shares | 92.04 | 92.04 | - |
EPS (Riyals) | 2.57 | 1.54 | (40.2 %) |
Profit for third quarter was SAR 20.16 million; 68.9 percent lower YoY, driven by lower revenue on decreased number of outpatients, and higher operating and non-operating expenses incurred from starting up the Beverly clinic in Jeddah.
On a sequential quarter basis, profit for the period fell 41.17 percent.
Item | Q3 2017 | Q3 2018 | Change |
---|---|---|---|
Revenues | 352.98 | 338.77 | (4.0 %) |
Gross Income | 133.30 | 111.87 | (16.1 %) |
Operating Income | 55.70 | 21.29 | (61.8 %) |
Net Income | 64.88 | 20.16 | (68.9 %) |
Average Shares | 92.04 | 92.04 | - |
EPS (Riyals) | 0.70 | 0.22 | (68.9 %) |
Item | Q2 2018 | Q3 2018 | Change |
---|---|---|---|
Revenues | 346.13 | 338.77 | (2.1 %) |
Gross Income | 116.91 | 111.87 | (4.3 %) |
Operating Income | 31.66 | 21.29 | (32.8 %) |
Net Income | 34.27 | 20.16 | (41.2 %) |
Average Shares | 92.04 | 92.04 | - |
EPS (Riyals) | 0.37 | 0.22 | (41.2 %) |
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
Q1 2009 | - | - | - | - | - | - |
Q2 2009 | - | - | - | - | - | - |
Q3 2009 | - | - | - | - | - | - |
Q4 2009 | - | - | - | - | - | - |
2009 | - | - | - | - | - | - |
Q1 2010 | - | - | - | - | - | - |
Q2 2010 | - | - | - | - | - | - |
Q3 2010 | - | - | - | - | - | - |
Q4 2010 | - | - | - | - | - | - |
2010 | - | - | - | - | - | - |
Q1 2011 | - | - | - | - | - | - |
Q2 2011 | - | - | - | - | - | - |
Q3 2011 | - | - | - | - | - | - |
Q4 2011 | - | - | - | - | - | - |
2011 | 436.84 | - | 159.99 | - | 40.98 | - |
Q1 2012 | - | - | - | - | - | - |
Q2 2012 | - | - | - | - | - | - |
Q3 2012 | - | - | - | - | - | - |
Q4 2012 | - | - | - | - | - | - |
2012 | 542.22 | 24.1 % | 248.36 | 55.2 % | 72.56 | 77.0 % |
Q1 2013 | - | - | - | - | - | - |
Q2 2013 | - | - | - | - | - | - |
Q3 2013 | - | - | - | - | - | - |
Q4 2013 | - | - | - | - | - | - |
2013 | 828.36 | 52.8 % | 430.49 | 73.3 % | 136.85 | 88.6 % |
Q1 2014 | 359.18 | - | 199.49 | - | 75.11 | - |
Q2 2014 | 347.08 | - | 185.78 | - | 88.17 | - |
Q3 2014 | 323.16 | - | 174.49 | - | 71.53 | - |
Q4 2014 | 369.34 | - | 190.01 | - | 78.37 | - |
2014 | 1,398.75 | 68.9 % | 749.76 | 74.2 % | 313.18 | 128.8 % |
Q1 2015 | 391.64 | 9.0 % | 208.99 | 4.8 % | 102.89 | 37.0 % |
Q2 2015 | 372.00 | 7.2 % | 203.88 | 9.7 % | 89.24 | 1.2 % |
Q3 2015 | 352.20 | 9.0 % | 183.23 | 5.0 % | 88.21 | 23.3 % |
Q4 2015 | 418.69 | 13.4 % | 214.04 | 12.6 % | 97.86 | 24.9 % |
2015 | 1,534.53 | 9.7 % | 810.13 | 8.1 % | 378.20 | 20.8 % |
Q1 2016 | 421.52 | 7.6 % | 216.62 | 3.7 % | 103.68 | 0.8 % |
Q2 2016 | 410.07 | 10.2 % | 212.49 | 4.2 % | 76.56 | (14.2 %) |
Q3 2016 | 379.09 | 7.6 % | 199.40 | 8.8 % | 91.10 | 3.3 % |
Q4 2016 | 404.96 | (3.3 %) | 199.88 | (6.6 %) | 87.04 | (11.1 %) |
2016 | 1,615.64 | 5.3 % | 828.39 | 2.3 % | 358.37 | (5.2 %) |
Q1 2017 | 393.53 | (6.6 %) | 180.47 | (16.7 %) | 107.04 | 3.2 % |
Q2 2017 | 351.28 | (14.3 %) | 138.63 | (34.8 %) | 58.97 | (23.0 %) |
Q3 2017 | 352.98 | (6.9 %) | 133.30 | (33.1 %) | 55.70 | (38.9 %) |
Q4 2017 | 364.60 | (10.0 %) | 145.47 | (27.2 %) | 73.06 | (16.1 %) |
2017 | 1,462.39 | (9.5 %) | 597.87 | (27.8 %) | 294.77 | (17.7 %) |
Q1 2018 | 395.11 | 0.4 % | 160.42 | (11.1 %) | 85.82 | (19.8 %) |
Q2 2018 | 346.13 | (1.5 %) | 116.91 | (15.7 %) | 31.66 | (46.3 %) |
Q3 2018 | 338.77 | (4.0 %) | 111.87 | (16.1 %) | 21.29 | (61.8 %) |
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
2008 | - | - | - | - | - | - |
2009 | - | - | - | - | - | - |
2010 | - | - | - | - | - | - |
2011 | 436.84 | - | 159.99 | - | 40.98 | - |
2012 | 542.22 | 24.1 % | 248.36 | 55.2 % | 72.56 | 77.0 % |
2013 | 828.36 | 52.8 % | 430.49 | 73.3 % | 136.85 | 88.6 % |
2014 | 1,398.75 | 68.9 % | 749.76 | 74.2 % | 313.18 | 128.8 % |
2015 | 1,534.53 | 9.7 % | 810.13 | 8.1 % | 378.20 | 20.8 % |
2016 | 1,615.64 | 5.3 % | 828.39 | 2.3 % | 358.37 | (5.2 %) |
2017 | 1,462.39 | (9.5 %) | 597.87 | (27.8 %) | 294.77 | (17.7 %) |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
Q1 2009 | - | - | - | - | - | - |
Q2 2009 | - | - | - | - | - | - |
Q3 2009 | - | - | - | - | - | - |
Q4 2009 | - | - | - | - | - | - |
2009 | - | - | - | - | - | - |
Q1 2010 | - | - | - | - | - | - |
Q2 2010 | - | - | - | - | - | - |
Q3 2010 | - | - | - | - | - | - |
Q4 2010 | - | - | - | - | - | - |
2010 | - | - | - | - | - | - |
Q1 2011 | - | - | - | - | - | - |
Q2 2011 | - | - | - | - | - | - |
Q3 2011 | - | - | - | - | - | - |
Q4 2011 | - | - | - | - | - | - |
2011 | 36.01 | - | 0.39 | - | 36.01 | 0.39 |
Q1 2012 | - | - | - | - | - | - |
Q2 2012 | - | - | - | - | - | - |
Q3 2012 | - | - | - | - | - | - |
Q4 2012 | - | - | - | - | - | - |
2012 | 61.99 | 72.2 % | 0.67 | - | 61.99 | 0.67 |
Q1 2013 | - | - | - | - | - | - |
Q2 2013 | - | - | - | - | - | - |
Q3 2013 | - | - | - | - | - | - |
Q4 2013 | - | - | - | - | - | - |
2013 | 137.20 | 121.3 % | 1.49 | - | 137.20 | 1.49 |
Q1 2014 | 80.16 | - | 0.87 | - | 80.16 | 0.87 |
Q2 2014 | 92.80 | - | 1.01 | - | 92.80 | 1.01 |
Q3 2014 | 74.36 | - | 0.81 | - | 74.36 | 0.81 |
Q4 2014 | 84.64 | - | 0.92 | - | 84.64 | 0.92 |
2014 | 331.97 | 142.0 % | 3.61 | - | 331.97 | 3.61 |
Q1 2015 | 105.39 | 31.5 % | 1.15 | - | 105.39 | 1.15 |
Q2 2015 | 91.79 | (1.1 %) | 1.00 | - | 91.79 | 1.00 |
Q3 2015 | 90.75 | 22.0 % | 0.99 | - | 90.75 | 0.99 |
Q4 2015 | 102.32 | 20.9 % | 1.11 | - | 102.32 | 1.11 |
2015 | 390.25 | 17.6 % | 4.24 | - | 390.25 | 4.24 |
Q1 2016 | 104.20 | (1.1 %) | 1.13 | - | 104.20 | 1.13 |
Q2 2016 | 74.07 | (19.3 %) | 0.80 | - | 74.07 | 0.80 |
Q3 2016 | 99.64 | 9.8 % | 1.08 | - | 99.64 | 1.08 |
Q4 2016 | 84.73 | (17.2 %) | 0.92 | - | 84.73 | 0.92 |
2016 | 362.64 | (7.1 %) | 3.94 | - | 362.64 | 3.94 |
Q1 2017 | 109.97 | 5.5 % | 1.19 | - | 109.97 | 1.19 |
Q2 2017 | 61.95 | (16.4 %) | 0.67 | - | 61.95 | 0.67 |
Q3 2017 | 64.88 | (34.9 %) | 0.70 | - | 64.88 | 0.70 |
Q4 2017 | 82.69 | (2.4 %) | 0.90 | - | 82.69 | 0.90 |
2017 | 319.49 | (11.9 %) | 3.47 | - | 319.49 | 3.47 |
Q1 2018 | 87.13 | (20.8 %) | 0.95 | - | 87.13 | 0.95 |
Q2 2018 | 34.27 | (44.7 %) | 0.37 | - | 34.27 | 0.37 |
Q3 2018 | 20.16 | (68.9 %) | 0.22 | - | 20.16 | 0.22 |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
2008 | - | - | - | - | - | - |
2009 | - | - | - | - | - | - |
2010 | - | - | - | - | - | - |
2011 | 36.01 | - | 0.39 | - | 36.01 | 0.39 |
2012 | 61.99 | 72.2 % | 0.67 | - | 61.99 | 0.67 |
2013 | 137.20 | 121.3 % | 1.49 | - | 137.20 | 1.49 |
2014 | 331.97 | 142.0 % | 3.61 | - | 331.97 | 3.61 |
2015 | 390.25 | 17.6 % | 4.24 | - | 390.25 | 4.24 |
2016 | 362.64 | (7.1 %) | 3.94 | - | 362.64 | 3.94 |
2017 | 319.49 | (11.9 %) | 3.47 | - | 319.49 | 3.47 |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2009 | - | - | - |
Q2 2009 | - | - | - |
Q3 2009 | - | - | - |
Q4 2009 | - | - | - |
2009 | - | - | - |
Q1 2010 | - | - | - |
Q2 2010 | - | - | - |
Q3 2010 | - | - | - |
Q4 2010 | - | - | - |
2010 | - | - | - |
Q1 2011 | - | - | - |
Q2 2011 | - | - | - |
Q3 2011 | - | - | - |
Q4 2011 | - | - | - |
2011 | 36.62 % | 20.91 % | 8.24 % |
Q1 2012 | - | - | - |
Q2 2012 | - | - | - |
Q3 2012 | - | - | - |
Q4 2012 | - | - | - |
2012 | 45.80 % | 20.53 % | 11.43 % |
Q1 2013 | - | - | - |
Q2 2013 | - | - | - |
Q3 2013 | - | - | - |
Q4 2013 | - | - | - |
2013 | 51.97 % | 21.68 % | 16.56 % |
Q1 2014 | - | - | - |
Q2 2014 | - | - | - |
Q3 2014 | - | - | - |
Q4 2014 | 53.60 % | 25.57 % | 23.73 % |
2014 | 53.60 % | 25.57 % | 23.73 % |
Q1 2015 | 53.05 % | 27.10 % | 24.96 % |
Q2 2015 | 53.39 % | 26.84 % | 24.46 % |
Q3 2015 | 52.93 % | 27.56 % | 25.09 % |
Q4 2015 | 52.79 % | 28.05 % | 25.43 % |
2015 | 52.79 % | 28.05 % | 25.43 % |
Q1 2016 | 52.27 % | 27.77 % | 24.87 % |
Q2 2016 | 51.57 % | 26.50 % | 23.17 % |
Q3 2016 | 51.71 % | 26.41 % | 23.34 % |
Q4 2016 | 51.27 % | 26.12 % | 22.45 % |
2016 | 51.27 % | 26.12 % | 22.45 % |
Q1 2017 | 49.90 % | 26.91 % | 23.20 % |
Q2 2017 | 46.99 % | 27.02 % | 23.30 % |
Q3 2017 | 43.41 % | 25.39 % | 21.40 % |
Q4 2017 | 40.88 % | 25.40 % | 21.85 % |
2017 | 40.88 % | 25.40 % | 21.85 % |
Q1 2018 | 39.47 % | 24.17 % | 20.26 % |
Q2 2018 | 38.12 % | 22.54 % | 18.44 % |
Q3 2018 | 37.01 % | 20.57 % | 15.52 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
2008 | - | - | - |
2009 | - | - | - |
2010 | - | - | - |
2011 | 36.62 % | 20.91 % | 8.24 % |
2012 | 45.80 % | 20.53 % | 11.43 % |
2013 | 51.97 % | 21.68 % | 16.56 % |
2014 | 53.60 % | 25.57 % | 23.73 % |
2015 | 52.79 % | 28.05 % | 25.43 % |
2016 | 51.27 % | 26.12 % | 22.45 % |
2017 | 40.88 % | 25.40 % | 21.85 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2009 | - | - | - |
Q2 2009 | - | - | - |
Q3 2009 | - | - | - |
Q4 2009 | - | - | - |
Q1 2010 | - | - | - |
Q2 2010 | - | - | - |
Q3 2010 | - | - | - |
Q4 2010 | - | - | - |
Q1 2011 | - | - | - |
Q2 2011 | - | - | - |
Q3 2011 | - | - | - |
Q4 2011 | - | - | - |
Q1 2012 | - | - | - |
Q2 2012 | - | - | - |
Q3 2012 | - | - | - |
Q4 2012 | - | - | - |
Q1 2013 | - | - | - |
Q2 2013 | - | - | - |
Q3 2013 | - | - | - |
Q4 2013 | - | - | - |
Q1 2014 | 55.54 % | 23.76 % | 22.32 % |
Q2 2014 | 53.53 % | 28.54 % | 26.74 % |
Q3 2014 | 54.00 % | 25.72 % | 23.01 % |
Q4 2014 | 51.45 % | 24.43 % | 22.92 % |
Q1 2015 | 53.36 % | 29.47 % | 26.91 % |
Q2 2015 | 54.81 % | 27.44 % | 24.67 % |
Q3 2015 | 52.02 % | 28.83 % | 25.77 % |
Q4 2015 | 51.12 % | 26.62 % | 24.44 % |
Q1 2016 | 51.39 % | 28.30 % | 24.72 % |
Q2 2016 | 51.82 % | 22.50 % | 18.06 % |
Q3 2016 | 52.60 % | 28.28 % | 26.29 % |
Q4 2016 | 49.36 % | 25.48 % | 20.92 % |
Q1 2017 | 45.86 % | 31.64 % | 27.94 % |
Q2 2017 | 39.46 % | 22.25 % | 17.64 % |
Q3 2017 | 37.76 % | 21.46 % | 18.38 % |
Q4 2017 | 39.90 % | 25.53 % | 22.68 % |
Q1 2018 | 40.60 % | 27.04 % | 22.05 % |
Q2 2018 | 33.78 % | 15.35 % | 9.90 % |
Q3 2018 | 33.02 % | 13.01 % | 5.95 % |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
Q1 2009 | - | - | - | - |
Q2 2009 | - | - | - | - |
Q3 2009 | - | - | - | - |
Q4 2009 | - | - | - | - |
Q1 2010 | - | - | - | - |
Q2 2010 | - | - | - | - |
Q3 2010 | - | - | - | - |
Q4 2010 | - | - | - | - |
Q1 2011 | - | - | - | - |
Q2 2011 | - | - | - | - |
Q3 2011 | - | - | - | - |
Q4 2011 | - | - | - | - |
Q1 2012 | - | - | - | - |
Q2 2012 | - | - | - | - |
Q3 2012 | - | - | - | - |
Q4 2012 | - | - | - | - |
Q1 2013 | - | - | - | - |
Q2 2013 | - | - | - | - |
Q3 2013 | - | - | - | - |
Q4 2013 | - | - | - | - |
Q1 2014 | 92.04 | - | - | 10.70 |
Q2 2014 | 92.04 | - | - | 11.69 |
Q3 2014 | 92.04 | - | - | 12.48 |
Q4 2014 | 92.04 | 3.61 | 3.61 | 12.38 |
Q1 2015 | 92.04 | 3.88 | 3.88 | 13.50 |
Q2 2015 | 92.04 | 3.87 | 3.87 | 12.67 |
Q3 2015 | 92.04 | 4.05 | 4.05 | 13.63 |
Q4 2015 | 92.04 | 4.24 | 4.24 | 14.70 |
Q1 2016 | 92.04 | 4.23 | 4.23 | 16.39 |
Q2 2016 | 92.04 | 4.03 | 4.03 | 15.20 |
Q3 2016 | 92.04 | 4.13 | 4.13 | 16.43 |
Q4 2016 | 92.04 | 3.94 | 3.94 | 17.32 |
Q1 2017 | 92.04 | 4.00 | 4.00 | 18.46 |
Q2 2017 | 92.04 | 3.87 | 3.87 | 17.09 |
Q3 2017 | 92.04 | 3.49 | 3.49 | 17.74 |
Q4 2017 | 92.04 | 3.47 | 3.47 | 15.75 |
Q1 2018 | 92.04 | 3.22 | 3.22 | 16.69 |
Q2 2018 | 92.04 | 2.92 | 2.92 | 15.07 |
Q3 2018 | 92.04 | 2.44 | 2.44 | 15.29 |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
2008 | - | - | - | - |
2009 | - | - | - | - |
2010 | - | - | - | - |
2011 | 92.04 | 0.39 | 0.39 | 6.03 |
2012 | 92.04 | 0.67 | 0.67 | 6.65 |
2013 | 92.04 | 1.49 | 1.49 | 9.84 |
2014 | 92.04 | 3.61 | 3.61 | 12.38 |
2015 | 92.04 | 4.24 | 4.24 | 14.70 |
2016 | 92.04 | 3.94 | 3.94 | 17.32 |
2017 | 92.04 | 3.47 | 3.47 | 15.75 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
Q1 2009 | - | - | - |
Q2 2009 | - | - | - |
Q3 2009 | - | - | - |
Q4 2009 | - | - | - |
Q1 2010 | - | - | - |
Q2 2010 | - | - | - |
Q3 2010 | - | - | - |
Q4 2010 | - | - | - |
Q1 2011 | - | - | - |
Q2 2011 | - | - | - |
Q3 2011 | - | - | - |
Q4 2011 | - | - | - |
Q1 2012 | - | - | - |
Q2 2012 | - | - | - |
Q3 2012 | - | - | - |
Q4 2012 | - | - | - |
Q1 2013 | - | - | - |
Q2 2013 | - | - | - |
Q3 2013 | - | - | - |
Q4 2013 | - | - | - |
Q1 2014 | - | - | - |
Q2 2014 | - | - | - |
Q3 2014 | - | - | - |
Q4 2014 | - | - | - |
Q1 2015 | - | - | - |
Q2 2015 | - | - | - |
Q3 2015 | - | - | - |
Q4 2015 | - | - | - |
Q1 2016 | 17.17 | 17.17 | 4.43 |
Q2 2016 | 17.16 | 17.16 | 4.56 |
Q3 2016 | 12.41 | 12.41 | 3.12 |
Q4 2016 | 18.62 | 18.62 | 4.23 |
Q1 2017 | 18.48 | 18.48 | 4.01 |
Q2 2017 | 19.45 | 19.45 | 4.41 |
Q3 2017 | 17.98 | 17.98 | 3.54 |
Q4 2017 | 15.52 | 15.52 | 3.42 |
Q1 2018 | 17.90 | 17.90 | 3.46 |
Q2 2018 | 20.02 | 20.02 | 3.88 |
Q3 2018 | 15.00 | 15.00 | 2.39 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
2008 | - | - | - |
2009 | - | - | - |
2010 | - | - | - |
2011 | - | - | - |
2012 | - | - | - |
2013 | - | - | - |
2014 | - | - | - |
2015 | - | - | - |
2016 | 18.62 | 18.62 | 4.23 |
2017 | 15.52 | 15.52 | 3.42 |
Q3 2018
2018
Period | Inpatient clinics | Outpatient clinics | Pharmacy Sales | Others |
---|---|---|---|---|
Q1 2014 | 207.07 | 85.01 | 64.94 | 2.16 |
Q2 2014 | 200.50 | 77.40 | 66.66 | 2.51 |
Q1 2015 | 224.99 | 91.95 | 70.24 | 4.46 |
Q2 2015 | 211.41 | 86.64 | 70.30 | 3.65 |
Q3 2015 | 200.38 | 85.53 | 63.54 | 2.76 |
Q4 2015 | 220.47 | 119.55 | 72.94 | 5.72 |
Q1 2016 | 241.22 | 100.20 | 73.04 | 7.06 |
Q2 2016 | 229.99 | 99.85 | 72.93 | 7.31 |
Q3 2016 | 224.32 | 89.88 | 62.16 | 2.72 |
Q4 2016 | 220.91 | 107.73 | 72.64 | 3.69 |
Q1 2017 | 242.80 | 104.89 | 71.94 | 4.27 |
Q2 2017 | 224.48 | 92.89 | 70.77 | 3.54 |
Q3 2017 | 133.39 | 85.39 | 60.16 | 3.27 |
Q4 2017 | 172.44 | 114.51 | 71.35 | 6.30 |
Q1 2018 | 214.32 | 109.10 | 68.50 | 3.20 |
Q2 2018 | 188.62 | 79.63 | 76.10 | 1.78 |
Q3 2018 | 184.16 | 98.93 | 53.64 | 2.04 |
Period | Inpatient clinics | Outpatient clinics | Pharmacy Sales | Others |
---|---|---|---|---|
2013 | - | - | 159.08 | 1.19 |
2014 | 807.92 | 323.31 | 257.32 | 10.20 |
2015 | 857.25 | 383.67 | 277.02 | 16.59 |
2016 | 916.44 | 397.66 | 280.76 | 20.77 |
2017 | 773.12 | 397.68 | 274.21 | 17.38 |
Item | Q3 2018 (e) | Q3 2018 (a) | Change |
---|---|---|---|
Average | 41.18 | 20.16 | (51.0 %) |
Item | Q3 2018 (e) | Q3 2018 (a) | Change |
---|---|---|---|
SNB Capital | 33.50 | 20.16 | (39.8) % |
OSOOL AND BAKHEET | 36.00 | 20.16 | (44.0) % |
AlJazira Capital | 43.20 | 20.16 | (53.3) % |
Sico | 52.00 | 20.16 | (61.2) % |
Current | |
Market Cap (M Riyal) | 7,169.92 |
Enterprise Value (EV) (M) | 9,599.81 |
Shares Outstanding ((M)) | 92.04 |
EPS ( Riyal) (TTM) | 2.20 |
Book Value (BV) ( Riyal) | 17.78 |
Par Value ( Riyal) | 10.00 |
Adjusted P/E (Last12) | 39.06 |
P/E (TTM) | 35.33 |
Price/book | 4.38 |
Return on Average Assets (%) (TTM) | 4.0 |
Return on Average Equity (%) (TTM) | 13.1 |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}